(5.11) Adverse Reactions/Side Effects Most common (5%) in clinical trials: injection-site nodule, nausea
A 5mg vial at the 0.25mg starting dose provides 20 weeks of doses, but the solution expires after 4 weeks
The choice between capsules or liquid is personal what truly matters is the products purity and quality
This is the schedule for Semaglutide, arguably the most recognized GLP-1 medication on the market
Multi-Peptide Advanced SERUM: Aqua/Water/Eau, Propanediol, Caprylic/Capric Triglyceride, Isopentyldiol, Ethylhexyl Polyhydroxystearate, Squalane, Tetradecane, Glyceryl Stearate Citrate, Butyrospermum Parkii (Shea) Butter, Polyglyceryl-3 Stearate, Helianthus Annuus (Sunflower) Extract, Oryza Sativa (Rice) Bran Extract, Mannitol, Phosphatidylcholine, Ferulic Acid, Arginine, Acetyl Hexapeptide-8, Copper Palmitoyl Heptapeptide-14, Palmitoyl sh-Hexapeptide-13 Serine SP Amide, Hydrolyzed Collagen, Rosmarinus Officinalis (Rosemary) Leaf Extract, Lactic Acid/Glycolic Acid Copolymer, Glycerin, Tocopherol, Pullulan, Lysolecithin, Sclerotium Gum, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dimethicone, Sodium Phytate, Diglycerin, Hydrogenated Lecithin, Silica, Cetyl Alcohol, Hydroxyacetophenone, Polysorbate 60, Sorbitan Isostearate, Sodium Hydroxide, Sodium Benzoate, Potassium Sorbate, Polyvinyl Alcohol, Decyl Glucoside, Xanthan Gum, Tocopheryl Acetate, Sodium Chloride, Citric Acid, Phenoxyethanol
Though overall the risk remains low, oral estradiol is associated with increased venous thromboembolism (VTE) risk, whereas transdermal estradiol was not found to be associated with significant increased risk of VTE.7 The reason for the discrepancy is thought to be the result of procoagulant factors being formed as a result of first pass hepatic metabolism for estradiol, a factor that doesnt apply to the transdermal route
)
